ORBIMED ADVISORS LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$6.0B
Holdings
140
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (140 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ARNAEURARENA PHARMACEUTICALS INC | 133,400 | $5.6B | 94.16% | |
| 102 | ANABANAPTYSBIO INC | 375,800 | $5.3B | 89.24% | |
| 103 | VRNAVERONA PHARMA PLC | 1,250,396 | $5.2B | 86.58% | |
| 104 | —RESTORBIO INC | 4,830,387 | $5.0B | 83.61% | |
| 105 | TBPHTHERAVANCE BIOPHARMA INC | 211,545 | $4.9B | 82.16% | |
| 106 | HCATHEALTH CATALYST INC | 179,598 | $4.7B | 78.92% | |
| 107 | —MENLO THERAPEUTICS INC | 1,751,295 | $4.7B | 78.87% | |
| 108 | 1K0IGM BIOSCIENCES INC | 80,760 | $4.5B | 76.21% | |
| 109 | IFRXINFLARX NV | 1,067,600 | $4.1B | 68.53% | |
| 110 | —APTOSE BIOSCIENCES INC | 659,000 | $3.9B | 65.78% | |
| 111 | ARGXARGENX SE | 28,591 | $3.8B | 63.29% | |
| 112 | —SYNLOGIC INC | 2,029,996 | $3.5B | 58.69% | |
| 113 | TREURTRILLIUM THERAPEUTICS INC | 801,000 | $3.2B | 54.38% | |
| 114 | KALVKALVISTA PHARMACEUTICALS INC | 420,641 | $3.2B | 54.08% | |
| 115 | NTLAINTELLIA THERAPEUTICS INC | 262,100 | $3.2B | 53.86% | |
| 116 | SNDXSYNDAX PHARMACEUTICALS INC | 290,000 | $3.2B | 53.46% | |
| 117 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $2.9B | 48.00% | |
| 118 | IMVTIMMUNOVANT INC | 179,500 | $2.8B | 46.96% | |
| 119 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $2.7B | 44.89% | |
| 120 | —NEUBASE THERAPEUTICS INC | 371,114 | $2.6B | 44.40% | |
| 121 | OPHTEURIVERIC BIO INC | 750,000 | $2.6B | 43.36% | |
| 122 | —APTINYX INC | 1,162,108 | $2.5B | 42.18% | |
| 123 | BTAIEURBIOXCEL THERAPEUTICS INC | 107,300 | $2.4B | 40.30% | |
| 124 | —AGILE THERAPEUTICS INC | 1,200,000 | $2.2B | 37.51% | |
| 125 | ARWRARROWHEAD PHARMACEUTICALS IN | 68,100 | $2.0B | 32.92% | |
| 126 | SAVACASSAVA SCIENCES INC | 250,000 | $1.5B | 25.71% | Call |
| 127 | APLSAPELLIS PHARMACEUTICALS INC | 50,485 | $1.4B | 22.72% | |
| 128 | BMY-RBRISTOL-MYERS SQUIBB CO | 350,000 | $1.3B | 22.35% | |
| 129 | —NOVUS THERAPEUTICS INC | 3,183,314 | $1.2B | 20.86% | |
| 130 | STROSUTRO BIOPHARMA INC | 104,800 | $1.1B | 17.97% | |
| 131 | —KITOV PHARMA LTD | 3,461,983 | $1.1B | 17.78% | |
| 132 | —FLEXION THERAPEUTICS INC | 133,000 | $1.0B | 17.60% | |
| 133 | —CURIS INC | 1,358,363 | $956.0M | 16.07% | |
| 134 | —ZAFGEN INC | 1,106,529 | $852.0M | 14.32% | |
| 135 | —INTERSECT ENT INC | 68,553 | $812.0M | 13.65% | |
| 136 | MBIOUSDMUSTANG BIO INC | 251,685 | $675.0M | 11.34% | |
| 137 | PTGXPROTAGONIST THERAPEUTICS INC | 66,909 | $472.0M | 7.93% | |
| 138 | —CATABASIS PHARMACEUTICALS IN | 44,398 | $184.0M | 3.09% | |
| 139 | OTICEUROTONOMY INC | 71,994 | $142.0M | 2.39% | |
| 140 | —BIOLINERX LTD | 69,240 | $92.0M | 1.55% |
PreviousPage 2 of 2